Search
for
Sort by
Research 211–240 of 777
- Tofacitinib Treatment in Patients With Active COVID-19 Infection
- Safety and efficacy of tofacitinib in 97 alopecia areata patients
- Combination of baricitinib and conventional immunomodulating therapy for alopecia totalis
- Systemic Treatment of Moderate to Severe Alopecia Areata in Adults: Updated Australian Expert Consensus Statement
- Abrocitinib Treatment in Diffuse Alopecia Areata: A Case Report and a Literature Review
- A Case of Alopecia Totalis with Lichen Planus Hypertrophicus Responded Excellently to Oral Tofacitinib-An Observation
- Upadacitinib for management of alopecia areata and rheumatoid arthritis: Letter to the editor
- Transcriptomic analyses of regenerating adult feathers in chicken
- Alopecia areata: What’s new in epidemiology, pathogenesis, diagnosis, and therapeutic options?
- Frontal Fibrosing Alopecia. An Example of Disrupted Aryl Hydrocarbon Receptor-Mediated Immunological Homeostasis in the Skin?
- New and Emerging Therapies for Alopecia Areata
- New Modalities in the Treatment of Refractory Alopecia Areata
- Cytokine Targeted Therapeutics for Alopecia Areata: Lessons from Atopic Dermatitis and Other Inflammatory Skin Diseases
- Understanding autoimmunity of vitiligo and alopecia areata
- Modulating immune responses in alopecia: therapeutic insights and potential targets of antisense oligonucleotides
- The prostaglandin synthases, COX-2 and L-PGDS, mediate prostate hyperplasia induced by low-dose bisphenol A
- The potential application of natural products in cutaneous wound healing: A review of preclinical evidence
- Repigmentation Competence in Vitiligo: Integrating Immune, Regulatory, Regenerative, and Microenvironmental Axes
- Evaluating the Therapeutic Potential of Ritlecitinib for the Treatment of Alopecia Areata
- A phase 2a trial of brepocitinib for cicatricial alopecia
- Profile of tofacitinib citrate and its potential in the treatment of moderate-to-severe chronic plaque psoriasis
- Upadacitinib for Alopecia Areata in Different Backgrounds: A Case Series
- Abrocitinib Improved Dupilumab-Resistant Severe Atopic Dermatitis with Comorbid Mild Alopecia Areata in a 12-Year-Old Boy: A Case Report with 1-Year Follow-Up
- Case report: Psoriasiform eczema with immune-mediated comorbidities treated with upadacitinib
- Baricitinib as a treatment for myasthenia gravis: A case report
- Immunopharmacological potential of Arctium lappa L. in immune-mediated skin diseases: A critical review of experimental and clinical evidence
- Targeted immunotherapy for hair regrowth and regeneration
- Forging the Future: 2018 Alopecia Areata Research Summit Summary Report
- Selection signatures of wool color in Gangba sheep revealed by genome-wide SNP discovery
- Evaluation of the efficacy and treatment-emergent adverse events of deuruxolitinib for moderate to severe alopecia areata: a dose-ranging meta-analysis of 1,372 randomized patients